Dubai: In line with objectives to enhance regional collaborations and support cancer patients in the UAE, US-based multinational pharmaceutical and biotechnology corporation, Pfizer recently signed an association deal with the UAE-based Friends of Cancer Patients (FOCP) and Emirates Oncology Society.
The Memorandum of Understanding strengthens Pfizer’s commitment to progressing oncology care, promoting early detection, and supporting cancer treatment in the country.
According to Ms. Sawsan Jafar, Chairperson of FCOP’s Board of Directors, new treatments have played a critical part in UAE patients’ fight and survival against cancer, especially when detected early.
The rate of cancer patients is expected to grow two-fold in the Gulf Corporation Council (GCC) countries by 2025 compared to the rest of the world, Dr. Humaid al-Shamsi, President of Emirates Oncology Society observed while stressing that early detection remains the ‘first and most critical defense against cancer.’